South Africa Preps for First New TB Vaccine in 100 Years
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
For the first time in more than 100 years, adults may finally have access to a vaccine that protects against tuberculosis, and South Africa is racing to make it available as quickly as possible.
The country's Department of Health is already laying the groundwork for the M72/AS01E vaccine, which is currently being tested in South Africa, Kenya, Zambia, Malawi and Indonesia. If clinical trials succeed and regulators approve it, the vaccine could transform TB prevention for adolescents and adults.
Right now, the only TB vaccine available is the BCG shot given to newborns and young children. That vaccine offers limited protection as people grow older, leaving a dangerous gap for adults who face the highest TB risks.
The new vaccine has already shown promising results in earlier trial phases. If approved by South Africa's Health Products Regulatory Authority, it would mark a historic breakthrough in the fight against a disease that continues to claim lives across the globe.
The Ripple Effect
The impact could extend far beyond individual health. The Gates Medical Research Institute and the Bill & Melinda Gates Foundation recently reached an agreement with the Serum Institute of India, the world's largest vaccine manufacturer, to produce and distribute doses globally.
Even more exciting for South Africa, the agreement includes plans for local pharmaceutical partners to gradually manufacture the vaccine right in the country. This move would create jobs, strengthen the nation's vaccine production capabilities and support economic growth while saving lives.
South Africa has set an ambitious goal of eliminating TB as a public health threat by 2030. This vaccine could be the game changer needed to make that target a reality, protecting millions of people who currently have no defense against the disease in adulthood.
The Department of Health says it stands ready to support both production and introduction of the vaccine once trial results come in and approval is granted. The preparation work happening now means that if the vaccine succeeds, South Africans won't have to wait years to access it.
A century is a long time to go without new tools to fight a deadly disease, but that wait may finally be coming to an end.
More Images
Based on reporting by Regional: south africa breakthrough (ZA)
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it
